Plasma Matrix Metalloproteinase-9 Levels Predict First-Time Coronary Heart Disease: An 8-Year Follow-Up of a Community-Based Middle Aged Population

BACKGROUND: The enzyme in matrix metalloproteinase (MMP)-9 has been suggested to be an important determinant of plaque degradation. While several studies have shown elevated levels in patients with coronary heart disease, results in prospective population based studies evaluating MMP-9 in relation t...

Descripción completa

Detalles Bibliográficos
Autores principales: Garvin, Peter, Jonasson, Lena, Nilsson, Lennart, Falk, Magnus, Kristenson, Margareta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4577098/
https://www.ncbi.nlm.nih.gov/pubmed/26389803
http://dx.doi.org/10.1371/journal.pone.0138290

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4577098/
https://www.ncbi.nlm.nih.gov/pubmed/26389803
http://dx.doi.org/10.1371/journal.pone.0138290

Ejemplares similares